These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 5414254)
61. Relapse of herpes simplex encephalitis after conventional acyclovir therapy. VanLandingham KE; Marsteller HB; Ross GW; Hayden FG JAMA; 1988 Feb; 259(7):1051-3. PubMed ID: 3339802 [TBL] [Abstract][Full Text] [Related]
62. [Herpes encephalitis in adults and interferon (author's transl)]. Vezinet F; Lebon P; Amoudry C; Gibert C Nouv Presse Med; 1981 Mar; 10(14):1135-8. PubMed ID: 6164043 [TBL] [Abstract][Full Text] [Related]
63. Efficacy of (E)-5-(2-bromovinyl)-2'-deoxyuridine against different herpes simplex virus strains in cell culture and against experimental herpes encephalitis in mice. Reefschläger J; Wutzler P; Thiel KD; Bärwolff D; Langen P; Sprössig M; Rosenthal HA Antiviral Res; 1982 Oct; 2(5):255-65. PubMed ID: 6295273 [TBL] [Abstract][Full Text] [Related]
64. Herpes simplex encephalitis: poor outcome despite adenine arabinoside therapy. Wenman WM; Brunton JL; Lank BA; Ronald AR Can Med Assoc J; 1982 Apr; 126(7):819-21. PubMed ID: 6280829 [No Abstract] [Full Text] [Related]
65. 5-Ethyl-2'-deoxyuridine as a systemic agent for treatment of herpes simplex virus encephalitis. Comparison of effects in a normal and immunosuppressed murine model. Davis WB; Oakes JE; Vacik JP; Rebert RR; Taylor JA Adv Ophthalmol; 1979; 38():140-50. PubMed ID: 525525 [No Abstract] [Full Text] [Related]
66. Vidarabine approved for herpes simplex virus encephalitis. FDA Drug Bull; 1978 Dec-1979 Jan; 8(6):36. PubMed ID: 720790 [No Abstract] [Full Text] [Related]
72. Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients. Sköldenberg B; Forsgren M; Alestig K; Bergström T; Burman L; Dahlqvist E; Forkman A; Frydén A; Lövgren K; Norlin K Lancet; 1984 Sep; 2(8405):707-11. PubMed ID: 6148470 [TBL] [Abstract][Full Text] [Related]
73. Induction of encephalitis in SJL mice by intranasal infection with herpes simplex virus type 1: a possible model of herpes simplex encephalitis in humans. Hudson SJ; Dix RD; Streilein JW J Infect Dis; 1991 Apr; 163(4):720-7. PubMed ID: 1849158 [TBL] [Abstract][Full Text] [Related]
74. Double-stranded RNA, an interferon inducer, in herpes simplex keratitis. Kaufman HE; Ellison ED; Waltman SR Am J Ophthalmol; 1969 Sep; 68(3):486-91. PubMed ID: 5807679 [No Abstract] [Full Text] [Related]
75. Experimental vaccinial keratoconjunctivitis. Effect of an interferon inducer (polyI:C). Moschini GB; O JO Arch Ophthalmol; 1972 Feb; 87(2):211-5. PubMed ID: 5057871 [No Abstract] [Full Text] [Related]
76. Factors indicative of outcome in a comparative trial of acyclovir and vidarabine for biopsy-proven herpes simplex encephalitis. Whitley RJ; Alford CA; Hirsch MS; Schooley RT; Luby JP; Aoki FY; Hanley D; Nahmias AJ; Soong SJ Infection; 1987; 15 Suppl 1():S3-8. PubMed ID: 3298070 [TBL] [Abstract][Full Text] [Related]
77. Herpes encephalitis: MR monitoring of response to acyclovir therapy. Lester JW; Carter MP; Reynolds TL J Comput Assist Tomogr; 1988; 12(6):941-3. PubMed ID: 3183128 [TBL] [Abstract][Full Text] [Related]
80. Increased interferon release and morphological alteration in human cells by repeated exposure to double-stranded RNA. Billiau A; Van den Berghe H; De Somer P J Gen Virol; 1972 Jan; 14(1):25-31. PubMed ID: 4258798 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]